Seshadri Neervannan
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 9SEC | TARSTarsus Pharmaceuticals, Inc. | Sell Plan | 4,56478,532 held (−5%) | $85.00 | $388K | -13.9% |
| Mar 24SEC | TARSTarsus Pharmaceuticals, Inc. | Sell Plan | 2,98982,791 held (−3%) | $66.75 | $200K | +9.6% |
| Mar 19SEC | TARSTarsus Pharmaceuticals, Inc. | Sell | 3,12593,979 held (−3%) | $69.42 | $217K | +5.4% |
| Mar 19SEC | TARSTarsus Pharmaceuticals, Inc. | Sell | 3,61090,369 held (−4%) | $68.71 | $248K | +6.5% |
| Mar 19SEC | TARSTarsus Pharmaceuticals, Inc. | Sell | 4,58985,780 held (−5%) | $67.00 | $307K | +9.2% |
| Mar 5SEC | TARSTarsus Pharmaceuticals, Inc. | Sell Plan | 8,36670,817 held (−11%) | $76.67 | $641K | -4.6% |
- Sell
COO Seshadri Neervannan sold $388K of TARS at $85.00 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Seshadri Neervannan sold $200K of TARS at $66.75 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Seshadri Neervannan sold $641K of TARS at $76.67 — pre-scheduled 10b5-1 plan sale.